LDLR and atherosclerosis: Deficiency of PK stabilizes LDLR protein expression, promotes hepatic LDL-C clearance and inhibits atherosclerosis in mice.140 All the evidence above suggest that LDLR still represents a promising therapeutic target for ASCVD treatment.